Symposium 8: Therapeutic approach: should it be personalized?
Within patients defined as having prediabetes either by fasting blood glucose, glucose tolerance test or HbA1c, trajectory analyzes show that changes in metabolic or inflammatory markers begin 10 years before the onset of type 2 DM. Therefore, it is of high clinical relevance to identify subgroups o...
Main Author: | Guillermo Marcucci |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Sello Editorial Lugones
2022-09-01
|
Series: | Revista de la Sociedad Argentina de Diabetes |
Subjects: | |
Online Access: | https://revistasad.com/index.php/diabetes/article/view/567 |
Similar Items
-
Symposium 13: Prediabetes and brain
by: Gustavo Díaz
Published: (2022-09-01) -
Diagnostic and therapeutic approach to spondylodiscitis in Spanish children through the RIOPed network: evaluation before and after the publication of the national consensus document
by: Laura Martín Pedraz, et al.
Published: (2024-08-01) -
Physiological birth in patients with previous cesarean section
by: Eduardo Sandeliz Cárdenas, et al.
Published: (2012-04-01) -
Longitudinal Characterization of the Gut Microbiota in the Diabetic ZDSD Rat Model and Therapeutic Potential of Oligofructose
by: Savanna N. Weninger, et al.
Published: (2023-05-01) -
Apendicitis poscolonoscopia: reporte de caso y revisión de la literatura
by: Camilo Ramírez Giraldo, et al.
Published: (2020-03-01)